What Men Should Know About BRCA Variant Testing

The genetic test Angelina Jolie helped make famous isn’t just for women. Certain at-risk men should consider it, too.

1:00 PM

Author | Michelle Jacobs, M.S., C.G.C.

In 2013, actress Angelina Jolie brought genetic testing for hereditary breast and ovarian cancer syndrome (HBOC) into the limelight by announcing that she had preventive surgery to remove her breasts. Last year, she announced another surgery to remove her ovaries and fallopian tubes.

SEE ALSO: Men with Prostate Cancer Should Have Genetic Testing, Study Says

Guiding her decision was a blood test that showed she was at increased risk of developing breast and ovarian cancer.

These declarations, which received wide media coverage, spurred many women to examine their family histories and their own cancer risks more closely, prompting some to seek genetic counseling.

However, discussion of the impact on men and their families has been largely absent, even though the condition affects both genders.

An inherited cancer syndrome, HBOC causes an increased risk of certain types of cancers — including ovarian cancer in women, prostate cancer in men, and breast and pancreatic cancer and melanoma in both genders.

HBOC is caused by mutations, or alterations, in the BRCA1 and BRCA2 genes. Such mutations are present in about 1 in 400 to 1 in 800 individuals, regardless of gender, and are more common in people of Ashkenazi Jewish descent (about 1 in 40).

Here are some common questions men might have about the need for and mechanics of such testing:

Which men should consider genetic testing for BRCA1 and BRCA2?

  • Those with personal or family history of male breast cancer

  • Those with personal or family history of at least two men with aggressive prostate cancers (Gleason score of 7 or greater)

  • Men with a family history of ovarian cancer; a female relative who developed breast cancer at a young age (earlier than 50) or developed multiple primary breast cancers; or three or more female relatives with breast cancer at any age

  • Men of Ashkenazi Jewish descent and personal or family history of breast, ovarian, or pancreatic cancers, aggressive prostate cancer, or melanoma

  • Those with known family history of a BRCA1 or BRCA2 mutation

How does genetic testing work?

At a genetic counseling appointment, a counselor and physician will collect family and personal history information from you to determine whether genetic testing may be a good option. If indicated, genetic testing is done via blood test.

What does it mean to have a BRCA1 or BRCA2 mutation?

Having a mutation in one of these genes does not mean a person will definitely develop cancer over his or her lifetime.

SEE ALSO: With Radiation Therapy, It Pays to Stay on Schedule

However, it does indicate an increased risk of cancer. Your health care team may recommend enhanced screening or prophylactic surgery. You can discuss this risk and options for management with a genetic counselor or a qualified physician.

Can men transmit this condition to their daughters?

Yes. Contrary to conventional thinking, each child of a man who has a BRCA1 or BRCA2 mutation has a 50 percent risk of carrying the same mutation, even if the man never develops cancer.

Regardless of whether you think you might change your own medical management based on these results, genetic testing can provide helpful information for relatives who may be at increased risk.

If your personal or family history is consistent with any of the above and you are interested in making an appointment for genetic counseling, the National Society of Genetic Counselors maintains a searchable database to help locate services in your area.


More Articles About: Wellness & Prevention BRCA gene Cancer and Genetics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories watch on hand
Health Lab
Tailored text messages not enough to improve mobility after heart issues
A Michigan Medicine report shows that adding a mobile health application to such devices yields mixed results. Tailored text messages to encourage high-risk people to move more may improve some short-term outcomes but doesn’t always improve physical activity levels for everyone.
cells colorful
Health Lab
Improvements in human genome databases offer a promising future for cancer research
A gene sequencing method called ribosome profiling has expanded our understanding of the human genome by identifying previously unknown protein coding regions. Also known as Ribo-seq, this method allows researchers to get a high-resolution snapshot of protein production in cells.
bacteria black background yellow cell
Health Lab
The surprising origin of a deadly hospital infection
Surprising findings from a Michigan Medicine study in Nature Medicine suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated with the patients themselves.
cancer cell
Health Lab
Language barriers in cancer care
Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 
nanoparticles floating green blue
Health Lab
Gene therapy for brain tumor shows promising early results in humans
Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.
map green teal
Health Lab
As Medicaid ‘unwinding’ continues, Michigan report provides key insights
Medicaid expansion’s impact on low-income Michigan residents included reduced uninsurance, increased primary and preventive care, and better financial health.